[
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb (NYSE:BMY) Collaborates With BioNTech For Antibody Development In Cancer Treatment",
    "summary": "Bristol-Myers Squibb (NYSE:BMY) recently announced a significant partnership with BioNTech SE to co-develop and co-commercialize the bispecific antibody BNT327, targeting multiple solid tumor types. This collaboration, alongside the European Commission's approval of a new formulation of Opdivo® for subcutaneous administration, may have added weight to the company's 4% share price rise over the past week. These events occurred in a market environment that saw an overall climb of 2%, suggesting...",
    "url": "https://finnhub.io/api/news?id=a70938043b6ecd7e93c1c73119c1d7747526250a570257d8ac67c82a6dce841e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748971178,
      "headline": "Bristol-Myers Squibb (NYSE:BMY) Collaborates With BioNTech For Antibody Development In Cancer Treatment",
      "id": 134987117,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb (NYSE:BMY) recently announced a significant partnership with BioNTech SE to co-develop and co-commercialize the bispecific antibody BNT327, targeting multiple solid tumor types. This collaboration, alongside the European Commission's approval of a new formulation of Opdivo® for subcutaneous administration, may have added weight to the company's 4% share price rise over the past week. These events occurred in a market environment that saw an overall climb of 2%, suggesting...",
      "url": "https://finnhub.io/api/news?id=a70938043b6ecd7e93c1c73119c1d7747526250a570257d8ac67c82a6dce841e"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Collaborates With BNTX for Oncology Candidate",
    "summary": "BMY strikes a billion-dollar deal with BNTX to co-develop BNT327, a bispecific antibody targeting PD-L1 and VEGF-A in solid tumors.",
    "url": "https://finnhub.io/api/news?id=144ad8aa77c2f51c3111b6813a5f8acee8d5bae700d4bdeaba19ff07fc12404c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748967060,
      "headline": "Bristol Myers Collaborates With BNTX for Oncology Candidate",
      "id": 134987120,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BMY strikes a billion-dollar deal with BNTX to co-develop BNT327, a bispecific antibody targeting PD-L1 and VEGF-A in solid tumors.",
      "url": "https://finnhub.io/api/news?id=144ad8aa77c2f51c3111b6813a5f8acee8d5bae700d4bdeaba19ff07fc12404c"
    }
  },
  {
    "ts": null,
    "headline": "Trump’s Tax Bill Is Testing the Dollar. This Red Flag Matters More.",
    "summary": "The dollar’s worst start to a year on record, Bristol Myers plans to develop new cancer drug, Apple’s WWDC is coming, and more news to start your day.",
    "url": "https://finnhub.io/api/news?id=83ba15b8d41090d9e8f3f24601c2cfbfc2d1cf0407d23b36b38d708419f6c23d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748947320,
      "headline": "Trump’s Tax Bill Is Testing the Dollar. This Red Flag Matters More.",
      "id": 134977002,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The dollar’s worst start to a year on record, Bristol Myers plans to develop new cancer drug, Apple’s WWDC is coming, and more news to start your day.",
      "url": "https://finnhub.io/api/news?id=83ba15b8d41090d9e8f3f24601c2cfbfc2d1cf0407d23b36b38d708419f6c23d"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Paying BioNTech Up to $11.1B in Cancer Drug Team-up",
    "summary": "At the heart of the biotech deal is a relatively new drug technology called PD-1/VEGF bispecific antibodies.",
    "url": "https://finnhub.io/api/news?id=d8c11e91cdda04ac4a031dcb145e5c3b8281da1e014df125da66ca6c711a60cc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748946600,
      "headline": "Bristol Myers Paying BioNTech Up to $11.1B in Cancer Drug Team-up",
      "id": 134977430,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "At the heart of the biotech deal is a relatively new drug technology called PD-1/VEGF bispecific antibodies.",
      "url": "https://finnhub.io/api/news?id=d8c11e91cdda04ac4a031dcb145e5c3b8281da1e014df125da66ca6c711a60cc"
    }
  },
  {
    "ts": null,
    "headline": "Trending tickers: Meta, TSMC, BioNTech, Applied Digital and BAT",
    "summary": "The latest investor updates on stocks that are trending on Tuesday.",
    "url": "https://finnhub.io/api/news?id=e65eb4b61ca807e4cd4ea13c9fc3f925a82f3084c8f65c3cfb55aa678d7b6fef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748943670,
      "headline": "Trending tickers: Meta, TSMC, BioNTech, Applied Digital and BAT",
      "id": 134976267,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The latest investor updates on stocks that are trending on Tuesday.",
      "url": "https://finnhub.io/api/news?id=e65eb4b61ca807e4cd4ea13c9fc3f925a82f3084c8f65c3cfb55aa678d7b6fef"
    }
  },
  {
    "ts": null,
    "headline": "Why BioNTech SE (BNTX) Skyrocketed On Monday",
    "summary": "We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are going to take a look at where BioNTech SE (NASDAQ:BNTX) stands against other top-performing stocks on Monday. BioNTech saw its share prices grow by 18.05 percent on Monday to finish at $113.10 apiece following news that it joined forces […]",
    "url": "https://finnhub.io/api/news?id=cbec7a034a23c7292799c20ed6bc95581a7db42b2fd9e4eaf58e55a9d4fb92d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748931776,
      "headline": "Why BioNTech SE (BNTX) Skyrocketed On Monday",
      "id": 134977445,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are going to take a look at where BioNTech SE (NASDAQ:BNTX) stands against other top-performing stocks on Monday. BioNTech saw its share prices grow by 18.05 percent on Monday to finish at $113.10 apiece following news that it joined forces […]",
      "url": "https://finnhub.io/api/news?id=cbec7a034a23c7292799c20ed6bc95581a7db42b2fd9e4eaf58e55a9d4fb92d1"
    }
  }
]